Angiogenesis, views and news. The 93rd Annual Meeting of the American Association for Cancer Research
Authors:
- Holger N LodeHLHolger N Lode
- J WenkelJWJ Wenkel
- Gerhard GaedickeGGGerhard Gaedicke
- 1 August 2002
- journal article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 2 (6) , 671-676
Abstract
The 93rd Annual Meeting of the American Association of Cancer Research was held in San Francisco, CA, USA. It was one of the largest conferences of its kind covering all aspects of cancer research with 6000 scientific presentations over a period of 5 days. The following meeting highlights are focused on a few selected developments in the field of tumour-induced angiogenesis, attempting a synthesis between educational sessions and original scientific presentations. Two important shifts in paradigms were reported at that meeting involving the biology of tumour-induced angiogenesis. Firstly, the generation of new blood vessels was demonstrated to dramatically depend on bone marrow-derived circulating endothelial precursor cells, thereby supplementing existing concepts of vessel generation by migration and proliferation of pre-existing mature endothelial cells. Secondly, the genetic stability of endothelial cells circumventing resistance to antiangiogenic therapy was challenged by the observation of resistance to hypoxia, which developed in tumour cells following antiangiogenic therapy. Both aspects are discussed in the following chapters with respect to their possible impact on the development of therapeutic strategies involving angiogenesis inhibition.Keywords
This publication has 9 references indexed in Scilit:
- Effect of p53 Status on Tumor Response to Antiangiogenic TherapyScience, 2002
- Tirapazamine: Prototype for a novel class of therapeutic agents targeting tumor hypoxiaSeminars in Oncology, 2002
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthNature Medicine, 2001
- Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrinsJournal of Cell Biology, 2001
- Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2 + AC133 + Endothelial Precursor CellsCirculation Research, 2001
- Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxiaExpert Opinion on Investigational Drugs, 2000
- Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursorsBlood, 2000
- Circulating endothelial precursors: mystery, reality, and promiseJournal of Clinical Investigation, 2000